Sabuwar na'ura tana kula da migraines bayan sun fara
Migraines suna da wuya a bi da su. Magunguna na miyagun ƙwayoyi suna da mummunar tasiri kuma sau da yawa basu da tasiri. Bugu da ƙari, idan aka kai a kai a kai, magungunan magungunan ƙwayoyi na iya haifar da ciwon kai "chronification," ko ciwon kai na ciwon kai. Sakamakon haka, akwai babban sha'awar bunkasa magungunan marasa magani don ƙaura, ciki har da neurostimulation (watau ƙin jiji).
Wannan na'urar Cefaly wani nau'in ƙwayar cutar ta jiki ne (e-TNS) wanda ke aikawa da ruwa ta hanyar lantarki wanda aka sanya a goshinsa. Yana aiki ta hanyar motsawa jijiyar na fata, wanda shine reshe na jijiyar cututtuka. Kwamitin Cefaly ya rigaya ya yarda da shi ta hanyar FDA don rigakafin ƙwayar cuta. A watan Disamba na shekara ta 2017, an sake shi don maganin muren ƙananan migraines kuma za'a iya amfani dasu bayan da farawa ta fara.
Menene na'urar Cefaly?
Shirin Cefaly ɗin shi ne babban sashi wanda ke haifar da halin yanzu ta amfani da batir AAA guda biyu. Ana amfani da halin yanzu a fadin fata na goshin, ta amfani da na'ura mai kwakwalwa. Wannan Cefaly yana motsa matsanancin ciwon magungunan ciwon daji da magunguna na ciwon ophthalmic, wanda hakan shi ne reshe na jijiyar cututtuka. Nada jijiya yana taka muhimmiyar rawa a cikin ciwon kai.
Cefaly ya zo a cikin misalai guda uku: Cefaly Acute, Cefaly Prevent, da Cefaly Dual. Cefaly Acute yayi kama da mummunan hare-haren migraine.
Anyi amfani da Cefaly Prevent don hana migraines. Kuma Cefaly Dual yana da saituna don duka biyu.
Wannan Cefaly Acute yana samar da wani ƙarami mai tsanani, tsawon minti 60. Cefaly Prevent ne ƙananan mita kuma za a iya amfani da shi yau da kullum.
Bisa ga masu sana'a, na'urar Cefaly ta karu da ƙaruwa a lokacin minti 14 na amfani.
A wannan lokacin, idan halin yanzu ya zama mai tsanani, za ka iya danna maballin don tabbatar da ƙarfin da kuma dakatar da wani ƙara karuwa a tsanani.
Mai sana'anta ya lissafa takaddama akan shafin yanar gizonta, wanda ya shafi mutane da:
- wani samfurin ƙarfe ko na'urar lantarki da aka gina a kai
- fama da zafi na asali ba a sani ba
- mai kwakwalwa na zuciya ko kwanto ko ƙarancin defibrillator mai sauƙi, wanda zai iya haifar da tsangwama tare da yin tafiya, turawar wuta, ko mutuwa
Yanayin aikin da e-TNS ke aiki ba shi da tabbas. Da farko dai, masana sun tsara cewa wannan neurostimulation yana motsa hankalin hawa a cikin hanya mai zafi. Duk da haka, wannan jaddada ba ta goyan bayan binciken binciken ba. Sabanin haka, an nuna cewa e-TNS canza gyaran ciwo a cikin wani tsari na sama.
Shirin FDA na Cefaly a matsayin magani ne bisa sakamakon sakamakon gwaje-gwajen Turai biyu: jarrabawar PREMICE da Nazarin Bincike na Labarai na Turai.
BABI NA KARANTA
TAMBAYOYAR DA KARANTA ta kasance gwajin da aka yi na Cefaly, wanda aka gudanar a tsakanin 2009 zuwa 2011 ta kamfanin haɗin gwiwar Belgian. Wannan binciken ya kasance mai yiwuwa, ko dogon lokaci, bincike wanda ya hada da marasa lafiya 67 tare da akalla biyu hare-haren migraine kowane wata.
A cikin wannan gwaji, akwai watanni ɗaya na farkon watanni kafin a sanya masu halartar koda hakikanin gaske ko sham (watau karya). Yanayin magani ya yi tsawon watanni uku.
Ga sakamakon binciken:
- Wadanda ke karbar Cefaly magani sun sami raguwa sosai a cikin ƙaura da kuma ciwon kai ta watanni uku na jiyya.
- Magunguna da suka karbi maganin Cefaly sun sha kashi kashi 29.7 cikin 100 na rani da kuma kashi 32.3 cikin dari na rashin jin dadi.
- A cikin kulawa ko sham, rukuni, raguwa a cikin kwanaki na gudun hijira da ciwon kai sun kasance kashi 4.9 cikin dari da kashi 3.4 cikin dari.
- A cikin gwajin, ko wadanda ke karbar maganin Cefaly, kashi 38.2 cikin 100 na marasa lafiya sun samu akalla kashi 50 na ragowar ƙaura a kowace wata.
- A cikin rukunin kulawa, kashi 12.1 cikin dari na mahalarta sun sami akalla kashi 50 na raguwa a cikin watanni na migraine.
- Yawanci, akwai raguwa mai mahimmanci a cikin kwanaki na migraine a cikin gwaji.
- Ko da yake ba mahimmanci ba ne, waɗanda ke karɓar maganin Cefaly sun bayar da rahoto akan raguwa da ƙananan migraines.
- Wa] anda suka yi amfani da Cefaly, sun bukaci kashi 36.7, maimakon maganin maganin ciwon kai.
- A wa] anda ke shan maganin sham, an samu raguwar kashi 0.4, a cikin maganin maganin maganin ciwon hauka.
- Babu wani mummunar sakamako a cikin waɗanda ke amfani da Cefaly.
- Cefaly zai iya zama mafi amfani ga mutanen dake da ƙwayar migraines da yawa, ko fiye da hudu a wata (watau kwanaki bakwai na migraine). A bayyane yake, ana gudanar da bincike don bincika wannan yawan mutane masu haƙuri.
Nazarin Harkokin Sanya Labarai na Turai
An kafa rajista ga dukan marasa lafiya wadanda suka sami na'urar Cefaly tsakanin watan Satumbar 2009 da Yuni 2012. Mafi yawan waɗannan masu amfani da su sun kasance a Faransa da Belgium. Bayan sun yi amfani da na'ura a tsakanin kwanaki 40 zuwa 80, an umarci marasa lafiya su shiga cikin binciken da yayi la'akari da gamsuwa da damuwa game da mummunar tasiri.
Sakamakon binciken wannan bayanan ya nuna cewa kimanin kashi 53 cikin dari na marasa lafiya sun gamsu da magani kuma suna son ci gaba da yin amfani da na'urar. Kimanin kashi 4 cikin 100 na marasa lafiya basu yarda da na'urar ba. Babu wani daga cikin wadannan gunaguni da ke fama da mummunar tasiri. Musamman ma, waɗannan masu amfani sun yi kuka game da jin dadin da na'urar ta haifar (watau "tingling"), barci a lokacin zaman, kuma ciwon kai bayan zaman.
Cefaly don Harkokin Mutuwar Migraine
Bisa ga sakamakon wani bazuwar, gwajin gwaji mai suna ACME (Magungunan Ciwon Halitta tare da Ƙarƙashin Ƙarƙashin Ƙarƙashin Ƙarshe), a watan Disamba na shekarar 2017, FDA ta amince da Cefaly don magance hare-haren hawan ƙaura kamar yadda suke faruwa. Tare da waɗannan ƙididdigar asibiti, yawan mutanen da ke da ƙauraran da za su amfana daga Cefaly sun karu da ninki goma. A cikin wannan binciken, an samu raguwar kashi 65 cikin raunin ƙwayar ƙwayar cutar migraines, kuma kashi 32 cikin dari na mahalarta ba su da lafiya a cikin awa daya.
Sakamako daga jarrabawar lakabi da aka yi la'akari da lafiyar da Cefaly ya yi don magance wani ƙaura mai ƙaura ne aka buga a cikin jaridar Neuromodulation a cikin watan Oktoba 2017. A cikin wannan binciken, Chou da abokan aiki sunyi amfani da Cefaly a cikin marasa lafiya 30 da ke fuskantar hijira ko dai tare da ko ba tare da aura ba. Don a hada da su a cikin binciken, wadannan marasa lafiya sun kasance suna kai hare-haren ƙaura zuwa akalla sa'o'i uku. Bugu da ƙari kuma, waɗannan mutane ba su dauki magungunan magani ba don kai harin.
An ba da magani tare da Cefaly na sa'a daya. A cikin sa'o'i daya da biyu bayan fara magani, an tambayi mahalarta suyi bayanin ciwon su ta hanyar amfani da ma'auni.
A cewar Chou da masu marubuta, a nan ne sakamakon binciken su Cefaly:
Tare da la'akari da ingancin gaske, ƙarfin ciwo ya rage kashi 57.0 cikin dari bayan magani guda daya da kashi 52.8 cikin sa'o'i biyu. Hanya irin wannan a maki biyu yana nuna cewa rage yawan ciwo yana da kyau don kiyaye akalla awa daya bayan ƙarshen neurostimulation. Yawan marasa lafiya ba tare da amfani da maganin ceto ba ne kashi 100 cikin dari bayan sa'o'i biyu da 65.4 bisa dari bayan sa'o'i 24. Rikicin marasa lafiya ba su karɓar magani na ceto a cikin sa'o'i 24 a cikin kungiyoyin placebo don maganin gwajin maganin ƙwayar maganin ƙwayar maganin ƙwayar maganin ƙwayar maganin ƙwayar maganin ƙwayar cuta.
Bayan bayanin kula, "magunguna masu ceto" suna nufin magunguna da aka ɗauka lokacin da magani na farko ba zai taimaka ba. A cikin wannan binciken, idan lokacin Cefaly ya kasa, to, masu halartar zasu dauki magungunan ceto. An yi amfani da magungunan ceto a sa'o'i biyu da 24.
Bugu da ƙari, yadda za a magance matsalolin hawan ƙaura, Chou da abokan aiki ba su lura da abubuwan da suka faru ba, kuma babu wani mahalarta da suka yi gunaguni game da magani.
Yana da wuya a kwatanta tasiri na Cefaly tare da magunguna da ake amfani dasu don magance ƙaura saboda bambance-bambance a cikin gwajin gwaji tsakanin nazarin. Duk da haka, ta hanyar amfani da ma'auni guda ɗaya, binciken da aka raba ya gano cewa sa'a daya bayan shan diclofenac NSAID (marasa lafiya), marasa lafiya sun nuna raguwar kashi 26.8 na ciwo mai tsanani idan aka kwatanta da kashi 17.1 cikin raunin ciwo na migraine ga wadanda ke daukar sumatriptan, kuma 52.7 kashi a cikin kashi na wadanda ke karɓar wannan taron Cefaly.
Game da yadda ake amfani da magungunan ceto, wasu bincike sun nuna cewa tsakanin kashi 20 da kashi 34 cikin dari na mutane suna buƙatar daukar magani na ceto tsakanin sa'o'i biyu da 24 bayan da za su yi nasara. Bugu da ƙari, a matsakaici, kashi 37 cikin dari na mutanen da suka dauki NSAID suna buƙatar daukar magungunan ceto. Kodayake, kashi 34.6 cikin 100 na marasa lafiya da ke karɓar wannan lokacin Cefaly suna buƙatar daukar magungunan ceto.
Daga qarshe, yana bayyana cewa Cefaly yana aiki da sauran jiyya ga ciwon kai na ƙaura ciki har da wadanda suka dace da NSAIDs. Ba kamar sauran magunguna ba, duk da haka, Cefaly ba shi da mummunar tasiri. Bugu da ƙari, masu bincike sun nuna cewa na'urar Cefaly zai iya zama mafi inganci idan an yi amfani dashi fiye da sa'o'i uku a harin.
Ƙarin Bayani Game da Migraines
Kimanin kashi 12 cikin dari na 'yan Amurkan na bunkasa ƙaura. Migraines sau uku ne a cikin mata. A cewar Burtaniya na Burtaniya na Bincike na Cututtuka na 2013, ƙwayar cuta ta kasance ta shida ta rashin lafiya a duniya kuma ta haifar da mummunar rashin daidaituwa ga rayuwa.
Migraines na faruwa a cikin hare-hare na matsakaicin matsanancin zafi. Kyakkyawan zafi shine ƙwaƙwalwa ko ƙuƙwalwa-yawanci yakan shafi ɗaya gefen kai. Yayin da ake kai hare-haren ƙaura, mutane suna samun karin haske ga haske da sauti. Masu fama da ƙwayar cuta suna iya jin haushi da kumbura.
Wasu mutane suna fama da rikice-rikicen ko dai kafin ko kuma a lokacin harin kai-tsaye. Wannan rikice-rikice ne ake kira auri. Wadannan rikice-rikice na iya zama na gani, kamar hasken walƙiya ko ɓoye makãho. Hakanan suna iya nunawa a matsayin hannu ko fuska.
Migigina triggers sun hada da:
- Damuwa
- Raguwa
- Rashin barci
- Bayyanawa zuwa haske
- Hormonal canje-canje
Gudanar da migraines zai iya zama ko dai m ko m. Ana amfani da jiyya mai mahimmanci don dakatar da kai hare-hare na migraine kuma mayar da aikin al'ada. Gudanar da kariya yana nufin canza saurin kai hari da tsanani.
Drugs amfani da m jiyya ga migraine sun hada da:
- NSAIDs
- Analgesic
- Triptans
A nan ne cututtuka masu guba don ƙaura:
- Beta-blockers (misali, metoprolol, propranolol, bisoprolol, da candesartan)
- Kwayoyin launi mai lamba Calcium (misali, flunarizine da verapamil)
- Masu amfani da magunguna (misali, topiramate da valproate)
Nutraceuticals, ciki har da riboflavin, coenzyme Q10, da magnesium, suna da ƙananan aiki wajen hana hare-haren hauka.
Rubuta a cikin Cephalalgia , Dodick, da kuma Martin sunyi sharhi game da mummunar tasirin masu cin nasara:
Duk da yake yana da alama ƙungiyar kwayoyi masu kama da juna, sakamakon sakamako daga meta-bincike ya nuna manyan bambance-bambance a cikin inganci da kuma jurewa a tsakanin magunguna. Rashin lafiyar kwayoyin cutar da kwayoyin cutar kwayoyi (CNS) ya haifar da kashi 15 cikin dari kuma yana iya haɗuwa da rashin aiki da rage yawan aiki. Abinda ya faru da abubuwan da suka faru da haɗari da keɓaɓɓe a cikin general, da kuma nasarori na CNS musamman, na iya haifar da jinkirin farawa ko ma guje wa wani magani mai mahimmanci.
> Sources:
> Yanar gizo Cefaly. www.cefaly.us.
> Chou DE, et al. Ƙarƙashin Ƙarƙashin Ƙarƙashin Ƙarƙashin Ƙarƙashin Ƙarƙashin Ƙarƙashin Ƙarƙashin Ƙarfin Migraine: Ƙaddamar Da Labarin Labaru akan Tsaro da Ƙari. 2017; 20: 678-683.
> Neman Koyarwar Novo na Cefaly Na'ura . FDA.
> A migraine. MedlinePlus.
> Riederer F, Penning S, Schoenen J. Transcutaneous Supraorbital Nerve Stimulation (t-SNS) tare da Cefaly [1] Na'ura don Rigakafin Rigakarewa: Wani Binciken Bayanin Da Ya Rasu. Pain da Far. 2015; 4: 135-137.